¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"first line therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • mesiolingual line angle
    ¾ÈÂÊÇôÂʼ±°¢
  • mesio-occlusal line angle
    ¾ÈÂʱ³Çո鼱°¢, ¾ÈÂʸ¹°¸²¸é¼±°¢
  • neonatal line
    ½Å»ý¾Æ¼±, ù¼ºÀå¼±
  • nuchal line
    ¸ñ´ú¹Ì¼±
  • nasolabial line
    ÄÚÀÔ¼ú¼±
  • oblique line
    ºø±Ý, »ç¼±
  • orbitomeatal line
    ´«È®±Ó±¸¸Û¼±, ¾È¿Í¿ÜÀ̵µ¼±
  • plane-line articulator
    Æò¸é¼±±³ÇÕ±â
  • pure line selection
    ¼ø°èµµÅÂ
  • pectinate line
    ºø»ì¼±
  • regression line
    ȸ±Í¼±
  • relaxed skin tension line
    ÇǺÎÇ®¸²¼±, ÇǺÎÀ̿ϼ±
  • spectral line
    ºÐ±¤¼±, ½ºÆåÆ®·³¼±
  • scapular line
    ¾î±ú»À¼±, °ß°©¼±
  • semilunar line
    ¹Ý´Þ¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • hypoglycemic shock therapy
    ÀúÇ÷´çÃæ°Ý¿ä¹ý, Àν¶¸°Ãæ°Ý¿ä¹ý
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»Æø¿ä¹ý
  • intensity modulated radiation therapy
    °­µµº¯Á¶¹æ»ç¼±¿ä¹ý
  • interference current therapy
    °£¼·ÆÄÄ¡·á
  • interpersonal therapy
    ´ëÀοä¹ý
  • interventional therapy
    ÁßÀç¿ä¹ý
  • intraopertive radiation therapy
    ¼ö¼úÁß¹æ»ç¼±Ä¡·á
  • marriage therapy
    (¢¡couples therapy) ºÎºÎ¿ä¹ý
  • multidisciplinary therapy
    ÁýÇÐÀû¿ä¹ý
  • myoblast transfer therapy
    ±ÙÀ°¸ð¼¼Æ÷ÀüÀÌ¿ä¹ý
  • occlusion therapy
    °¡¸²Ä¡·á
  • occupational therapy
    ÀÛ¾÷¿ä¹ý
  • orthodontic therapy
    ±³Á¤¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • gingival line
    Ä¡Àº¼±(öÍó»àÊ).
  • gluteal line<³ª> linea glutea
    µÐºÎ±Ù¼±, µÐ±Ù¼±(ÔëÐÉàÊ).
  • gluteal line<³ª> linea glutea
    µÐºÎ±Ù ¼±, µÐ±Ù ¼±(ÔëÐÉàÊ).
  • growth line
    ¼ºÀå¼±(¡­àÊ).
  • heteroploid cell line
    À̼öü¼¼Æ÷°è
  • highest nuchal line
    ÃÖ»óÇ×¼±(õÌß¾ú£àÊ).
  • highest nuchal line
    ¸ÇÀ§¸ñ´ú¹Ì¼±
  • highest nuchal line
    ÃÖ»ó Ç× ¼±(õÌß¾ú£àÊ), ¸ÇÀ§ ¸ñ´ú¹Ì ¼±.
  • iliopectineal line
    ÀåÄ¡°ñ¼±(íóö»ÍéàÍ).
  • iliopectineal line
    ÀåÄ¡°ñ¼±(ÀåÄ¡°ñ¼±).
  • inbred line
    ¼ø°è
  • indwelling line
    À¯Ä¡°ü
  • inferior gluteal line
    ¾Æ·¡º¼±â±Ù¼±
  • phosphorus line
    Àμ±(ìÝàÊ).
  • plane line articulator
    Æò¼±±³ÇÕ±â(øÁàÊÎáùêÐï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • developmental line
    ¹ßÀ°À¶ÇÕ¼±(¡­ë×ùêàÊ).
  • developmental line
    ¹ß´Þ¼±(Û¡Ó¹àÊ)
  • digastic line
    À̺¹¼±
  • diploid cell line
    À̹èü¼¼Æ÷°è(á¬øàͧ)
  • direct disposal line
    Á÷Á¢¹è°ü°è.
  • double line hemorrhage
    µÎÁÙ ÃâÇ÷, Áß¼±(ñìàÊ) ÃâÇ÷
  • embryonic line
    ¹èż±(ÛÏ÷ÃàÊ).
  • epiphyseal line
    »À³¡ ¼±, °ñ´Ü ¼±(ÍéÓ®àÊ).
  • epiphyseal line
    »À³¡¼±, °ñ´Ü¼±(ÍéÓ®àÊ).
  • epiphyseal line
    »À³¡¼±
  • fixation line
    Áֽü±
  • focal line
    ÃÊÁ¡¼±(õ¥ïÇàÊ).
  • germ line
    ¹è¼±(ÛÏàÊ).
  • germ line theory
    ³»¸²¹°·Á¹Þ±â¼³ (Ç×ü´Ù¾ç¼ºÀÇ)
  • gingival line
    Ä¡Àº¼±(öÍó»àÊ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
FMP faculty mentorship program; first menstrual period; fructose monophosphate
FMU first morning urine
FPRA first pass radionuclide angiogram
Fr1 first fraction
FRS Fellow of the Royal Society; ferredoxin-reducing substance; first rank symptom; furosemide
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GL germ line
HEP G-2 hepatoma cell line
HEL human erythroleukaemia cell line
HuH 7 human hepatoma cell line
HL-60 human leukemia cell line
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fluoride therapy
    ºÒ¼Ò Ä¡·á, ºÒ¼Ò óġ
  • heat and cold therapy
    ³Ã¿Â ¿ä¹ý
    Â÷°¡¿î ÆÐµå¿Í ¶ß°Å¿î ÆÐµå¸¦ ¹ø°¥¾Æ°¡¸ç º´¼Ò¿¡ ´ë°í Ç÷¾× ¼øÈ¯À» ÃËÁø½Ã۰í ÅëÁõÀ» ¿ÏÈ­½ÃŰ´Â ¹æ¹ý.
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
  • infrared laser therapy
    Àû¿Ü¼± ·¹ÀÌÀú ¿ä¹ý
    µ¿ÀǾî=cold laser thera
  • initial therapy
    Ãʱâ Ä¡·á
  • insulin convulsive therapy combined
    Àν¶¸° °æ·Ã º´ÇÕ Ä¡·á, Àν¶¸° °æ·Ã º´ÇÕ ¿ä¹ý
  • irreversible occlusal therapy
    ºñ°¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, ºñ°¡¿ªÀû ±³ÇÕ Ä¡·á
  • laser therapy
    ·¹ÀÌÀú Ä¡·á
    ÁÖ·Î ÃâÇ÷ÀÌ Àû¾î¾ß Çϰųª µ¿ÅëÀÌ ½ÉÇÑ È¯ÀÚÀÇ ¼ö¼úÀ̳ª »óóÀÇ À¶ÇÕ, Á¶Á÷ÀÇ ÆÄ±« µî¿¡ »ç¿ëµÈ´Ù.
  • light therapy
    ±¤¼± Ä¡·á
  • microwave therapy
    ±ØÃÊ´ÜÆÄ ¿ä¹ý
    ÆÄÀå 1 m ÀÌÇÏ, 1 mm ÀÌ»óÀÇ ÀüÀÚÆÄ¸¦ ÀÌ¿ëÇÏ´Â Àü±â¿ä¹ý. ¸¶ÀÌÅ©·Î¿þÀÌºê ¿ä¹ý , ¸¶ÀÌÅ©·ÎÆÄ ¿ä¹ýÀ̶ó°íµµ ÇÑ´Ù. º¸Åë ÀÇ·á¿ë¿¡´Â 12.5 cmÀÇ ÆÄÀåÀÌ Ã¤¿ëµÇ°í ÀÖ´Ù. ¸¶±×³×Æ®·ÐÀ̶ó´Â Áø°ø°ü¿¡¼­ ¹ßÁøµÇ¾î ¹Ý¿øÇü ¶Ç´Â °¢ÇüÀÇ Á¶»ç ÀåÄ¡·Î 5~10 cmÀÇ °Å¸®¿¡¼­ ȯºÎ¸¦ Á¶»çÇÑ´Ù. ÀÎü¿¡ Á¶»çÇÏ¿´À» ¶§ 3~4 cm¿¡¼­ ´ëºÎºÐ Èí¼öµÇ°í, ±× ¿¡³ÊÁö´Â ¿­·Î º¯ÇÑ´Ù. Áï, ½É´Þ¼ºÀº ÃÊ´ÜÆÄº¸´Ù ÀÛ°í Àû¿Ü¼±º¸´Ù´Â Å©´Ù. ±×·¸°Ô ±íÁö ¾ÊÀº Á¶Á÷¿¡ ´ëÇÑ ¿Â¿­¿ä¹ýÀ¸·Î ¾²À̸ç, ³ú, ´«, °íȯ µî°ú °°ÀÌ Ç÷ÇàÀÌ ÀûÀº ±â°ü¿¡¼­´Â °ú¿­µÉ À§ÇèÀÌ ÀÖÀ¸¹Ç·Î Á¶»çÇÒ ¶§ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
  • music therapy
    À½¾Ç ¿ä¹ý
  • non-reversible therapy
    ºñ°¡¿ªÀûÀÎ Ä¡·á
  • nonvital pulp therapy technique
    ½ÇȰ Ä¡¼ö Ä¡·á ¼ú½Ä
  • occlusal splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • occlusal therapy
    ±³ÇÕ Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
pulse therapy A short, intensive course of pharmacotherapy, usually given at intervals such as weekly or monthly; often used in chemotherapy of malignancy.
(05 Mar 2000)
hormonal therapy Treatment of cancer by alteration of the hormonal balance. Some cancer will only grow in the presence of certain hormones.
(09 Oct 1997)
hormone replacement therapy In females, treatment with sex hormones for a number for reasons, including menopause, partial or full hysterectomy, or amenorrhoea.In women, treatment with sex hormones is indicated for a number of reasons, including menopause, partial or full hysterectomy, or amenorrhoea. After menopause, conjugated oestrogens, estradiol, or estrone sulfate are given to reduce pain during intercourse, limit blood vessel effects, and prevent loss of bone mass. After radical hysterectomy, conjugated oestrogens are given for similar reasons. After menopause or partial hysterectomy, progestin is administered at the same time to offset an increased risk of endometrial cancer. In some amenorrhoeas, oestrogen is given to restore menses; if the therapy is unsuccessful, this may indicate the presence of pathology, for instance, pituitary tumour. Benefits for postmenopausal women include a lowered risk of heart attack (oestrogen lowers LDL and raises HDL levels), and prevention of osteoporosis, since the rate of bone loss is directly linked to a drop in oestrogen levels (see perimenopause). Medical opinion about the hazard posed by such therapy remains divided. Some studies have indicated increased incidence of breast cancer; however, a comprehensive 1992 review of the literature contradicted this finding.
(05 Mar 2000)
hormone therapy Treatment which results in the raising or lowering of hormone levels. Changes in levels can effect some breast cancers, those that need hormones for growth.
(16 Dec 1997)
puva therapy Photochemotherapy using a psoralen compound as the photosensitizing agent and ultraviolet light type a (uva).
(12 Dec 1998)
human gene therapy <molecular biology, technique> Insertion of normal DNA directly into cells to correct a genetic defect.
(09 Oct 1997)
serum therapy Treatment of an infectious disease by injection of an antitoxin or serum containing specific antibody.
Synonym: serum therapy.
(05 Mar 2000)
shock therapy See: electroshock therapy.
(05 Mar 2000)
short-wave therapy The use of focused short radio waves to produce local hyperthermia in an injured person or diseased body area.
(12 Dec 1998)
hyperbaric oxygen therapy <physiology> A pressurised chamber that allows for the delivery of oxygen in higher concentrations for therapeutic benefit.
Useful in the treatment of severe burns, peripheral vascular disease, carbon monoxide poisoning and decompression illness.
(04 Mar 1998)
social network therapy A type of therapy involving the assembling of all persons emotionally or functionally important to the patient for the purpose of affecting behavioural change in the patient.
(05 Mar 2000)
social therapy <psychiatry> A psychiatric rehabilitative therapy to improve a patient's social functioning.
(05 Mar 2000)
socioenvironmental therapy Therapy whose primary emphasis is on the physical and social structuring of the environment to promote interpersonal relationships which will be influential in reducing behavioural disturbances of patients.
(12 Dec 1998)
solar therapy Treatment of disease by exposure to sunlight.
(05 Mar 2000)
somatic cell gene therapy The repair or replacement of a defective gene within somatic tissue.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • bread line
    »§¹è±ÞÀ»¹Þ´Â»ç¶÷
  • building line
    (µµ·Î µûÀ§¿¡ ÀÓÇÏ´Â)°ÇÃàÁ¦ÇѼ±
  • catch line
    ÁÖÀǸ¦ ²ô´Â) ¼±Àü ¹®±¸;Ç¥Á¦
  • chorus line
    ÄÚ·¯½º ¶óÀÎ(ÁÖ¿ª±Þ ¹è¿ì¸¸ÀÌ ³ÑÀ» ¼ö ÀÖ´Â,¹«´ë Àü¸éÀÇ ¹é¼±)
  • chow line
    (±º´ë µî¿¡¼­)±Þ½Ä ¹Þ±â À§ÇØ ¼± ÁÙ
  • coasting line
    ¿¬¾ÈÇ×·Î
  • color line
    (»ç¿Ü.°æÁ¦.Á¤Ä¡Àû) ¹éÀÎ.ÈæÀÎÀÇ Â÷º° À庮
  • contour line
    µî°í¼±;µî½É¼±
  • credit line
    Å©·¹µðÆ®¶óÀÎ(´º½º.±â»ç.»çÁø.±×¸²ÀÇ º¹Á¦ µî¿¡ ºÙÀÌ´Â Á¦°øÀÚÀÇ À̸§ µîÀ» ¾´ °Í);½Å¿ë(¿Ü»ó)Çѵµ¾×;½Å¿ëÀå °³¼³ Çѵµ;½Å¿ëÇѵµ
  • crow line
    ÀÏÁ÷¼±(beeline)
  • date line
    ³¯Â¥ º¯°æ¼±;³¯Â¥±âÀÔ¼±;(±â»çµî¿¡)¹ß½ÅÁö¿Í ³¯Â¥¸¦ ±âÀÔÇÑ´Ù
  • datum line
    ±âÁؼ±
  • destruct line
    (¹Ì»çÀÏÀÇ)ÀÚÆø¼±
  • dotted line
    Á¡¼±;(Áöµµ¿¡ Àû¾î ³ÖÀº)¿¹Á¤ ÄÚ½º;¹«Á¶°Ç µ¿ÀÇÇÏ´Ù
  • end line
    ³¡(ÇѰè,°æ°è)À» ³ªÅ¸³»´Â ¼±;(Å״Ͻº,³ó±¸,¹Ì½Ä Ã౸ µîÀÇ)¿£µå ¶óÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á